Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spontaneous coronary artery dissection in an underrepresented region: insights from the Serbian (RS) SCAD registry.

Frontiers in cardiovascular medicine·2026
Same author

Harmonizing patient-reported outcome measures for nasal complaints using traditional and machine learning methods.

International journal of medical informatics·2026
Same author

Harmonization of SDQ and ASEBA Phenotypes: Measurement Variance Across Cohorts.

Journal of psychopathology and behavioral assessment·2025
Same author

The Effects of Bariatric Surgery on the Requirement for Antihypertensive Treatment in Type 2 Diabetes: Insights from a Long-Term Follow-Up Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2024
Same author

Harmonizing the CBCL and SDQ ADHD scores by using linear equating, kernel equating, item response theory and machine learning methods.

Frontiers in psychology·2024
Same author

Genotype-Environment Interaction in ADHD: Genetic Predisposition Determines the Extent to Which Environmental Influences Explain Variability in the Symptom Dimensions Hyperactivity and Inattention.

Behavior genetics·2024

Related Experiment Video

Updated: Jun 30, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Amiodaron treatment and thyroid autoimmunity markers.

Zeljka Aleksić1, Aleksandar Aleksić, Vladimir Mitov

  • 1Nuclear Medicine Service of Health Center Zajećar, Novo Nordisk Pharma d.o.o. Belgrade, Serbia. lukaal@ptt.yu

Hellenic Journal of Nuclear Medicine
|September 26, 2008
PubMed
Summary

Autoimmune thyroid diseases are common, especially in women. This study found amiodarone treatment may increase thyroid peroxidase antibodies (TPOAb) in women and with longer treatment duration.

Related Experiment Videos

Last Updated: Jun 30, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

  • Endocrinology
  • Immunology
  • Pharmacology

Background:

  • Autoimmune diseases of the thyroid gland (ADTG) involve serum thyroid autoantibodies (TAB).
  • Thyroid autoantibodies are prevalent in the general population, with higher incidence in women.
  • Amiodarone (AMD), an iodine-rich antiarrhythmic, has potential cytotoxic effects on the thyroid.

Purpose of the Study:

  • To determine the prevalence of thyroid autoantibodies in patients on chronic amiodarone (AMD) treatment.
  • To investigate the relationship between AMD treatment duration and thyroid autoantibody levels.

Main Methods:

  • A two-year prospective study of 96 consecutive patients (55 male, 41 female) on chronic AMD treatment.
  • Analysis of serum thyroid autoantibodies (TAB) and thyroid function in relation to AMD treatment.
  • Comparison of antibody levels based on sex and treatment duration (≤24 months vs. >24 months).

Main Results:

  • Thyroid autoantibodies were found at similar concentrations in AMD-treated patients compared to the general population.
  • A statistically significant higher frequency of increased thyroid peroxidase antibodies (TPOAb) was observed in female patients on AMD.
  • TPOAb levels were significantly higher in patients treated with AMD for longer than 24 months.

Conclusions:

  • While overall TAB prevalence is similar to the general population, AMD treatment may increase TPOAb, particularly in women.
  • Longer amiodarone treatment duration (>24 months) is associated with elevated TPOAb levels.
  • These findings highlight a potential link between amiodarone therapy and thyroid autoimmunity, warranting further investigation.